mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.6 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.6 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |